Kite Pharma, Inc. - Product Pipeline Review - 2015

Published: Dec, 2015 | Pages: 44 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Kite Pharma, Inc. - Product Pipeline Review - 2015

Summary

Global Markets Direct's, 'Kite Pharma, Inc. - Product Pipeline Review - 2015', provides an overview of the Kite Pharma, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Kite Pharma, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Kite Pharma, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Kite Pharma, Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Kite Pharma, Inc.'s pipeline products

Reasons to Buy

- Evaluate Kite Pharma, Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Kite Pharma, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Kite Pharma, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Kite Pharma, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Kite Pharma, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Kite Pharma, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Kite Pharma, Inc. Snapshot 5
Kite Pharma, Inc. Overview 5
Key Information 5
Key Facts 5
Kite Pharma, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Kite Pharma, Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Kite Pharma, Inc. - Pipeline Products Glance 11
Kite Pharma, Inc. - Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
Kite Pharma, Inc. - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Kite Pharma, Inc. - Unknown Stage Pipeline Products 14
Unknown Products/Combination Treatment Modalities 14
Kite Pharma, Inc. - Drug Profiles 15
Cellular Immunotherapy to Inhibit NY ESO-1 for Oncology 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
KTEC-19 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Cellular Immunotherapy to Target EGFR vIII for Glioblastoma, Brain Cancer, Head and neck cancer 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Cellular Immunotherapy to Target HPV-16 E6 Protein for Cancer 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Cellular Immunotherapy to Target MAGE A3 for Oncology 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Cellular Immunotherapy to Target MAGE A3 and A6 for Oncology 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Cellular Immunotherapy for Hematological Malignancies and Solid Tumors 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Cellular Immunotherapy to Target HPV-16 E7 Protein for Head and Neck Cancer and Cervical Cancer 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Cellular Immunotherapy to Target SSX2 for Solid Tumor 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
Kite Pharma, Inc. - Pipeline Analysis 31
Kite Pharma, Inc. - Pipeline Products by Target 31
Kite Pharma, Inc. - Pipeline Products by Route of Administration 32
Kite Pharma, Inc. - Pipeline Products by Molecule Type 33
Kite Pharma, Inc. - Pipeline Products by Mechanism of Action 34
Kite Pharma, Inc. - Recent Pipeline Updates 35
Kite Pharma, Inc. - Dormant Projects 41
Kite Pharma, Inc. - Locations And Subsidiaries 42
Head Office 42
Other Locations & Subsidiaries 42
Appendix 43
Methodology 43
Coverage 43
Secondary Research 43
Primary Research 43
Expert Panel Validation 43
Contact Us 43
Disclaimer 44

List of Tables

Kite Pharma, Inc., Key Information 5
Kite Pharma, Inc., Key Facts 5
Kite Pharma, Inc. - Pipeline by Indication, 2015 7
Kite Pharma, Inc. - Pipeline by Stage of Development, 2015 9
Kite Pharma, Inc. - Monotherapy Products in Pipeline, 2015 10
Kite Pharma, Inc. - Phase II, 2015 11
Kite Pharma, Inc. - Phase I, 2015 12
Kite Pharma, Inc. - Preclinical, 2015 13
Kite Pharma, Inc. - Unknown, 2015 14
Kite Pharma, Inc. - Pipeline by Target, 2015 31
Kite Pharma, Inc. - Pipeline by Route of Administration, 2015 32
Kite Pharma, Inc. - Pipeline by Molecule Type, 2015 33
Kite Pharma, Inc. - Pipeline Products by Mechanism of Action, 2015 34
Kite Pharma, Inc. - Recent Pipeline Updates, 2015 35
Kite Pharma, Inc. - Dormant Developmental Projects,2015 41
Kite Pharma, Inc., Subsidiaries 42